GA
TMCI icon

Gagnon Advisors’s Treace Medical Concepts TMCI Stock Holding History

Gagnon Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.11M Buy
+1,534,034
New +$4.22M 3.88% 13
2026
Q1 		– Sell
-1,534,034
Closed -$3.76M – 25
2025
Q4 		$3.76M Buy
1,534,034
+565,570
+58% +$2.46M 2.39% 18
2025
Q3 		$6.5M Buy
968,464
+138,194
+17% +$902K 4.01% 12
2025
Q2 		$4.88M Buy
830,270
+340,379
+69% +$2.22M 3.28% 15
2025
Q1 		$4.11M Hold
489,891
– – 2.9% 17
2024
Q4 		$3.64M Hold
489,891
– – 2.33% 19
2024
Q3 		$2.84M Buy
+489,891
New +$3.15M 1.84% 21

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Gagnon Advisors's TMCI Position: Q2 2026 in Review

Gagnon Advisors opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 1,534,034 shares worth $6.11M. The stake represents 3.88% of the portfolio and ranks #13 among its holdings. This is a return to the name: Gagnon Advisors previously reported a position in TMCI as recently as Q4 2025.

Gagnon Advisors first reported a position in TMCI in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.5M in Q3 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Gagnon Advisors held 1,534,034 shares of Treace Medical Concepts worth $6.11M as of Q2 2026.
  • Treace Medical Concepts was a new Gagnon Advisors position in Q2 2026.
  • Treace Medical Concepts made up 3.88% of Gagnon Advisors's portfolio in Q2 2026, its #13 holding.
  • Gagnon Advisors first reported a position in Treace Medical Concepts in Q3 2024 and has held it in 7 quarters since.
  • Gagnon Advisors's Treace Medical Concepts position peaked at $6.5M in Q3 2025.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Gagnon Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.